Abstract
Objectives
The objective of this study is to report on the performance of the MRI-guided VABB in our center and to look at the long-term outcome of biopsies with benign histology over a period of 19 years.
Methods
In a single-center retrospective review study, data of 600 VABB procedures performed between September 1999 and March 2017 were evaluated. We collected patient demographics, histopathological diagnosis at MRI-VABB, and basic lesion characteristics (size, location). Data from the Belgian Cancer Registry was cross-referenced with our database to find out which patients with benign MRI-VABB results developed a malignant lesion over time.
Results
These 600 VABB procedures were performed in 558 women with a mean patient age of 51.8 years (range 18–82 years). Our technical success rate was 99.3%. We found 27.67% B5 lesions, 9.82% B3 lesions, and 0.17% B4 lesions. Of 362 benign MRI-guided VABBs, follow-up data was available for a mean follow-up period of 7.6 years (0.8–18.3). Only one (0.3%) biopsy was a false negative lesion after MRI-guided VABB during follow-up. Short-term FU-MRI provided no increase in detection rate.
Conclusion
The accuracy of MRI-guided VABB is high with a very low false negative rate of 0.3% on long-term follow-up. The value of short-term FU-MRI for every case after MRI-guided VABB may be questioned.
Key Points
• MRI-guided vacuum-assisted breast biopsies yield a large portion of clinically relevant lesions (9.82% B3, 0.17% B4, and 27.67% B5 lesions).
• The false negative biopsy rate of MRI-guided VABB in this study with a mean follow-up time of 7.6 years was only 0.3%.
• Performing a short-term follow-up MRI after a benign MRI-guided VABB concordant to the MRI appearance may be questioned.
Similar content being viewed by others
Abbreviations
- BI-RADS:
-
Breast imaging-reporting and data system
- CNB:
-
Core needle biopsy
- DCIS:
-
Ductal carcinoma in situ
- EUSOMA:
-
European Society of Breast Cancer Specialists
- FU-MRI:
-
Follow-up MRI
- IDA:
-
Invasive ductal adenocarcinoma
- ILA:
-
Invasive lobular adenocarcinoma
- LCIS:
-
Lobular carcinoma in situ
- LIQ:
-
Lower inner quadrant
- LOQ:
-
Lower outer quadrant
- MX:
-
Mammography
- NHSBSP:
-
National Health Service Breast Cancer Screening Program
- UIQ:
-
Upper inner quadrant
- UOQ:
-
Upper outer quadrant
- US:
-
Ultrasound
- VABB:
-
Vacuum-assisted biopsy of the breast
References
Bennani-Baiti B, Bennani-Baiti N, Baltzer PA (2016) Diagnostic performance of breast magnetic resonance imaging in non-calcified equivocal breast findings: results from a systematic review and meta-analysis. PLoS One 11:99–100
Bick U, Trimboli RM, Athanasiou A et al (2020) Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging 11. https://doi.org/10.1186/s13244-019-0803-x
Morris EA, Comstock CE, Lee CH et al (2013) ACR BI-RADS Magnetic Resonance Imaging. In: D'Orsi CJ, Sickles EA, Mendelson EB et al. ACR BIRADS Atlas, Breast Imaging Reporting and Data System. Reston, VA: Amercian College of Radiology
Wildiers H, Stordeur S, Vlayen J et al (2013) Breast cancer in women: diagnosis, treatment and follow-up. In: KCE Rep. 143 – 3rd Ed. Brussels, Belgium, Belgian Health Care Knowledge Centre (KCE)
Spick C, Schernthaner M, Pinker K et al (2016) MR-guided vacuum-assisted breast biopsy of MRI-only lesions: a single center experience. Eur Radiol 26:3908–3916. https://doi.org/10.1007/s00330-016-4267-9
Imschweiler T, Haueisen H, Kampmann G et al (2014) MRI-guided vacuum-assisted breast biopsy: comparison with stereotactically guided and ultrasound-guided techniques. Eur Radiol 24:128–135. https://doi.org/10.1007/s00330-013-2989-5
Li J, Dershaw DD, Lee CH, Kaplan J, Morris EA (2009) MRI follow-up after concordant, histologically benign diagnosis of breast lesions sampled by MRI-guided biopsy. AJR Am J Roentgenol 193:850–855. https://doi.org/10.2214/AJR.08.2226
Rauch GM, Dogan BE, Smith TB, Liu P, Yang WT (2012) Outcome analysis of 9-gauge MRI-guided vacuum-assisted core needle breast biopsies. AJR Am J Roentgenol 198:292–299. https://doi.org/10.2214/AJR.11.7594
Perlet C, Heywang-Kobrunner SH, Heinig A et al (2006) Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer 106:982–990. https://doi.org/10.1002/cncr.21720
Malhaire C, El Khoury C, Thibault F et al (2010) Vacuum-assisted biopsies under MR guidance: results of 72 procedures. Eur Radiol 20:1554–1562. https://doi.org/10.1007/s00330-009-1707-9
Meeuwis C, Veltman J, Van Hall HN et al (2012) MR-guided breast biopsy at 3T: diagnostic yield of large core needle biopsy compared with vacuum-assisted biopsy. Eur Radiol 22:341–349. https://doi.org/10.1007/s00330-011-2272-6
Pinkney D, Chikarmane S, Giess C (2019) Do benign-concordant breast MRI biopsy results require short interval follow-up imaging? Report of longitudinal study and review of the literature. Clin Imaging 57:50–55. https://doi.org/10.1016/j.clinimag.2019.05.007
Hayward J, Ray K, Wisner D, Joe B (2016) Follow-up outcomes after benign concordant MRI-guided breast biopsy. Clin Imaging 40:1034–1039. https://doi.org/10.1016/j.clinimag.2016.06.005
Huang M, Speer M, Dogan B et al (2017) Imaging-concordant benign MRI-guided vacuum-assisted breast biopsy may not warrant MRI follow-up. AJR Am J Roentgenol 208:916–922. https://doi.org/10.2214/AJR.16.16576
Shaylor SD, Heller SL, Melsaether AN et al (2014) Short interval follow-up after a benign concordant MR-guided vacuum assisted breast biopsy - is it worthwhile? Eur Radiol 24:1176–1185. https://doi.org/10.1007/s00330-014-3125-x
Wallis M, Tarvidon A, Helbich T, Schreer I (2007) Guidelines from the European Society of Breast Imaging for diagnostic interventional breast procedures. Eur Radiol 17:581–588. https://doi.org/10.1007/s00330-006-0408-x
Heywang-Köbrunner SH, Bick U, Bradley WG et al (2001) International investigation of breast MRI: results of a multicentre study ( 11 sites ) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 11:531–546
Perlet C, Heinig A, Prat X et al (2002) Multicenter study for the evaluation of a dedicated biopsy device for MR-guided vacuum biopsy of the breast. Eur Radiol 12:1463–1470. https://doi.org/10.1007/s00330-002-1376-4
Hefler L, Casselman J, Amaya B et al (2003) Follow-up of breast lesions detected by MRI not biopsied due to absent enhancement of contrast medium. Eur Radiol 13:344–346. https://doi.org/10.1007/s00330-002-1713-7
Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Garrido L (2005) Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J 11:236–241. https://doi.org/10.1111/j.1075-122X.2005.21499.x
Krug B, Hellmich M, Ulhaas A et al (2016) Vacuum-assisted breast biopsies (VAB) carried out on an open 1.0T MR imager: influence of patient and target characteristics on the procedural and clinical results. Eur J Radiol 85:1157–1166. https://doi.org/10.1016/j.ejrad.2016.02.030
Merle N, Despeyroux S, Lombry Y, et al (2011) HTA Summary report: MRI-guided vacuum-assisted breast biopsy (VABB). Available via https://www.has-sante.fr/upload/docs/application/pdf/2012-02/hta_summary_report_mriguided_vacuum-assisted_breast_biopsy__vabb_.pdf
Shin S, Schneider HB, Cole FJ, Laronga C (2006) Follow-up recommendations for benign breast biopsies. Breast J 12:413–417. https://doi.org/10.1111/j.1075-122X.2006.00302.x
Mann RM, Balleyguier C, Baltzer PA et al (2015) Breast MRI: EUSOBI recommendations for women’ s information. Eur Radiol 25:3669–3678. https://doi.org/10.1007/s00330-015-3807-z
Taskin F, Soyder A, Tanyeri A, Öztürk VS, Ünsal A (2017) Lesion characteristics, histopathologic results, and follow-up of breast lesions after MRI-guided biopsy. Diagn Interv Radiol 23:333–338. https://doi.org/10.5152/dir.2017.17004
Ferré R, Ianculescu V, Ciolovan L et al (2016) Diagnostic performance of MR-guided vacuum-assisted breast biopsy: 8 years of experience. Breast J 22:83–89. https://doi.org/10.1111/tbj.12519
Acknowledgments
We want to thank the Belgian Cancer Registry for providing us the long-term follow-up data of the patients who underwent a MRI-guided VABB in our hospital and hence making this study possible.
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is J.W. Casselman.
Conflict of interest
The authors of this manuscript declare relationships with the following companies:
J.W. Casselman provides presentations for Philips and receives clients for Philips. Also, he organizes workshops for Leica-Devicor Mammotome. None of the other authors have any conflict of interest.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was obtained from all subjects (patients) in this study.
Ethical approval
Institutional Review Board approval was obtained.
Study subjects or cohorts overlap
A minor subgroup of our study (52 patients) was already included in a prior multicenter study by Heywang-Köbrunner SH et al, Eur Radiol (2001) 11:531-546. Also, data of the VABB procedures of these 52 patients was used in the three following publications: Perlet et al, Eur Radiol. (2002) 12(6):1463–70; Hefler et al, Eur Radiol (2003) 13(2):344–6 and Perlet et al, Cancer (2006) 106(5):982–90. Our new dataset includes 507 additional patients for a total of 600 biopsies, now in a single-center setting, with a much more extensive follow-up available for analysis of the false negative rate.
Methodology
• retrospective
• observational
• performed at one institution
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lambert, J., Steelandt, T., Heywang-Köbrunner, S.H. et al. Long-term MRI-guided vacuum-assisted breast biopsy results of 600 single-center procedures. Eur Radiol 31, 4886–4897 (2021). https://doi.org/10.1007/s00330-020-07392-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-020-07392-6